Cytomx Therapeutics, Inc. · NASDAQ:CTMX

Kynam Capital Management, LP reported a 6.90% stake in Cytomx Therapeutics, Inc. (Schedule 13G/A)

Event Mar 31, 2026 · Filed May 15, 2026

Kynam Capital Management, LP reported a 6.90% stake in Cytomx Therapeutics, Inc., 0 shares, as a passive investor on Mar 31, 2026. Filed May 15, 2026 (Schedule 13G/A).

Stake
6.90%
Shares
0
Intent
Passive
What changed
Stake changed
Filed together
3 holders

The filing in full

HolderStakeShares
Kynam Capital Management, LP6.90%0
Kynam Capital Management GP, LLC6.90%0
Yue Tang6.90%0

Source

View original at SEC

Related